BRIEF published on 07/16/2026 at 18:05, 1 month 10 days ago PREDILIFE's semi-annual liquidity contract review as of June 30, 2026 Liquidity Transactions Actions PREDILIFE Half-year Review
BRIEF published on 07/02/2026 at 18:05, 1 month 24 days ago Termination of the liquidity contract between PREDILIFE and TSAF Liquidity Contract Termination Euronext Growth TSAF PREDILIFE
BRIEF published on 07/01/2026 at 18:05, 1 month 25 days ago Results of the PREDILIFE General Meeting Capital Artificial Intelligence General Assembly PREDILIFE Resolutions Adopted
BRIEF published on 06/29/2026 at 20:05, 1 month 27 days ago Predilife: Update on the FDA procedure and 2025 financial report FDA Artificial Intelligence Financial Report Judicial Reorganization PREDILIFE
BRIEF published on 06/02/2026 at 08:05, 2 months 24 days ago Predilife: 2025 Review and Advances in Predictive Medicine Cancer Screening 2025 Financial Results Restructuring Strategy FDA Denseerisk Personalized Prediction
BRIEF published on 04/07/2026 at 08:05, 4 months 19 days ago Predilife outlines its strategy to maximize its industrial and financial potential Treasury PREDILIFE MammoRisk Industrial Strategy Risk Prediction
BRIEF published on 03/02/2026 at 19:05, 5 months 24 days ago PREDILIFE is making progress in submitting DenSeeRisk to the FDA FDA PREDILIFE MammoRisk Breast Cancer DenSeeRisk
BRIEF published on 01/16/2026 at 18:05, 7 months 10 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 12/17/2025 at 18:35, 8 months 9 days ago Major validation of the MammoRisk strategy against breast cancer PREDILIFE MammoRisk Breast Cancer Personalized Screening WISDOM Study
BRIEF published on 12/10/2025 at 18:05, 8 months 16 days ago PREDILIFE raises €900,000 Artificial Intelligence Fundraising Convertible Bonds Dilution PREDILIFE
Published on 08/27/2026 at 02:35, 1 hour 12 minutes ago Galantas Gold Reports Second Quarter 2026 Results
Published on 08/27/2026 at 02:00, 1 hour 47 minutes ago Algo Grande Copper Announces Upsizing of Private Placement
Published on 08/27/2026 at 00:05, 3 hours 42 minutes ago Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Published on 08/26/2026 at 23:00, 4 hours 47 minutes ago Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 5 hours 17 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/27/2026 at 03:00, 46 minutes ago Hong Kong Fashion Fest presents eight flagship programmes for its third edition
Published on 08/26/2026 at 23:05, 4 hours 41 minutes ago Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 9 hours 2 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 9 hours 6 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 9 hours 17 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:02, 9 hours 44 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 9 hours 47 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 10 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 10 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
